Soft Tissue Sarcoma Update, Issue 1, 2017 (Video Program)

Activity and tolerability of the tyrosine kinase inhibitors regorafenib and pazopanib in patients with STS
3:45 minutes.

Classification, incidence and management of sarcomas

Integration of the recently FDA-approved agents trabectedin and eribulin into the treatment algorithms for metastatic liposarcoma and leiomyosarcoma

Recent FDA approval of olaratumab in combination with doxorubicin and integration into the treatment algorithm for advanced STS

Role of tyrosine kinase inhibitors and immune checkpoint inhibitors in STS